Apollon Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $675K | Sell |
17,583
-76
| -0.4% | -$2.92K | 0.01% | 684 |
|
|
2025
Q1 | $684K | Sell |
17,659
-620
| -3% | -$24K | 0.02% | 624 |
|
|
2024
Q4 | $618K | Buy |
18,279
+1,634
| +10% | +$55.3K | 0.01% | 673 |
|
|
2024
Q3 | $680K | Sell |
16,645
-62
| -0.4% | -$2.54K | 0.02% | 606 |
|
|
2024
Q2 | $643K | Sell |
16,707
-813
| -5% | -$31.3K | 0.02% | 593 |
|
|
2024
Q1 | $751K | Sell |
17,520
-2,240
| -11% | -$96K | 0.02% | 549 |
|
|
2023
Q4 | $732K | Buy |
19,760
+9,145
| +86% | +$339K | 0.03% | 553 |
|
|
2023
Q3 | $385K | Buy |
10,615
+799
| +8% | +$29K | 0.02% | 621 |
|
|
2023
Q2 | $350K | Buy |
9,816
+382
| +4% | +$13.6K | 0.02% | 702 |
|
|
2023
Q1 | $336K | Sell |
9,434
-873
| -8% | -$31.1K | 0.02% | 653 |
|
|
2022
Q4 | $362K | Sell |
10,307
-1,560
| -13% | -$54.8K | 0.03% | 606 |
|
|
2022
Q3 | $349K | Buy |
11,867
+3,509
| +42% | +$103K | 0.03% | 554 |
|
|
2022
Q2 | $455K | Sell |
8,358
-111
| -1% | -$6.04K | 0.04% | 449 |
|
|
2022
Q1 | $461K | Buy |
8,469
+486
| +6% | +$26.5K | 0.03% | 483 |
|
|
2021
Q4 | $440K | Buy |
+7,983
| New | +$440K | 0.03% | 491 |
|
|
2020
Q3 | – | Sell |
-673
| Closed | -$34K | – | 366 |
|
|
2020
Q2 | $34K | Buy |
+673
| New | +$34K | 0.02% | 297 |
|